Oncotelic
在场
Oncotelic 是一家在股票代码 OTLC (US) 下上市的公司。
高管
查看带有其 7 名主要高管的组织结构图
Oncotelic 搜索最多的简介
- Vuong Trieu, Chairman of the Board and Chief Executive Officer
- Steven King, Director
- David Diamond, Director
创建提醒
跟踪 Oncotelic 的高管变动
生物技术
Oncotelic 拥有 2,318 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- AgomAb Therapeutics 刚刚宣布为 89 筹款数百万美元。 (公布2024十月29号).
- Seaport Therapeutics 刚刚宣布为 225 筹款数百万美元。 (公布2024十月25号).
- TuHura Biosciences and Kintara Therapeutics have merged (公布2024十月20号)..
生物技术 行业的其他推荐联系人
消息
Oncotelic 的最新新闻稿
- Press Releases – Oncotelic
- Oncotelic News powered by B2i Technologies - SmartWireOncotelic News powered by B2i Technologies - SmartWire
- Press Releases – Oncotelic
- Press Releases – Oncotelic
- MATEON’S PHASE 2 GLOBAL STUDY FOR OT-101/ TGF-β INHIBITOR AGAINST COVID-19 CLEARED FOR PATIENT ENROLLMENT IN ARGENTINA. | Mateon Therapeutics
- MATEON TO PARTICIPATE IN MERIDIAN CLINICAL TRIALS SUMMIT | Mateon Therapeutics
- RSS News Feeds | Mateon Therapeutics
- MATEON TO PARTICIPATE IN BIO INVESTOR FORUM DIGITAL | Mateon Therapeutics
- MATEON ANNOUNCES FIRST PATIENT ENROLLED IN ARTI-19: A MULTICENTER INTERVENTIONAL STUDY OF ARTISHIELD™ AGAINST COVID-19 | Mateon Therapeutics
- MATEON THERAPEUTICS TO INITIATE COMMERCIALIZATION OF ARTISHIELD™. | Mateon Therapeutics
- View more press releases Close
通过电子邮件
